Cargando…

Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug naïve in Limbe, Cameroon

Detalles Bibliográficos
Autores principales:	Agyingi, L, Barengolts, D, Mayr, L, Kinge, T, MBida, M, Nyambi, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441775/ http://dx.doi.org/10.1186/1742-4690-9-S2-P158

Ejemplares similares

P04-02. Increased breadth and potency of the neutralizing antibody response among dually-HIV-1-infected individuals
por: Powell, RL, et al.
Publicado: (2009)

The Evolution of HIV-1 Diversity in Rural Cameroon and its Implications in Vaccine Design and Trials
por: Powell, Rebecca, et al.
Publicado: (2010)

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2016)

Oral lesions among HIV seropositive individuals in an era of generic HAART: markers of HAART efficacy?
por: Vasudevan, Janani, et al.
Publicado: (2012)

A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2016)

Effectiveness of pegylated interferon alfa plus HAART in HIV/HBV treatment-naïve coinfected patients
por: Mata-Marín, JA, et al.
Publicado: (2010)

Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
por: Tossonian, HK, et al.
Publicado: (2010)

Efficacy and safety of TDF+FTC+EFV in naïve patients initiating HAART; an observational study comparing Atripla Vs Truvada/Sustiva exposure
por: Sanchez, Carlos Alberto, et al.
Publicado: (2010)

Retention in an antiretroviral therapy programme during an era of decreasing drug cost in Limbe, Cameroon
por: Mosoko, Jembia J, et al.
Publicado: (2011)

High level of adherence to HAART among refugees and internally displaced persons on HAART in western equatorial region of Southern Sudan
por: Salami, O, et al.
Publicado: (2010)

Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus
por: Mayr, LM, et al.
Publicado: (2012)

Trends in human papillomavirus (HPV) infection among HIV-positive women in the pre-HAART and HAART era in a Nigerian clinic
por: Onigbogi, MO, et al.
Publicado: (2010)

Naturally occurring protease inhibitor resistance mutations and their frequencies in HIV proviral sequences of drug-naïve sex workers in Nairobi, Kenya
por: Sampathkumar, Raghavan, et al.
Publicado: (2014)

The prognosis of patients with dissociated virological and immunological responses to HAART
por: Jevtovic, DJ, et al.
Publicado: (2010)

P04-14. Sequential HIV-1 isolates from infected individuals reveals emergence of neutralization sensitive HIV-1 strains in the course of infection
por: Nyambi, PN, et al.
Publicado: (2009)

Immune response after vaccination of HIV infected individuals receiving HAART with overlapping gag peptides pulsed on autologous cells
por: Kløverpris, H, et al.
Publicado: (2012)

Anal and cervical cytologic abnormalities among HIV-infected women in the era of HAART
por: Kojic, EM, et al.
Publicado: (2009)

HIV-1 infection in dendritic cells in HAART suppressed patients
por: Maldonado, lrvin M, et al.
Publicado: (2006)

Mesenteric fat thickness in a group of HIV patients on HAART
por: Lee, SS, et al.
Publicado: (2010)

Characteristic of HIV/AIDS infected patients at the detection and HAART initiation
por: Holban, Tiberiu, et al.
Publicado: (2014)

Transmitted drug resistance associated with transmission clusters in newly diagnosed antiretroviral-naïve patients in Northern Greece
por: Skoura, L, et al.
Publicado: (2010)

Factors associated with treatment modification during the first year of contemporary HAART
por: Martin, N, et al.
Publicado: (2010)

High preterm delivery rates associated with initiation of HAART during pregnancy
por: Taylor, GP, et al.
Publicado: (2010)

Five-year outcomes of HAART at a non-governmental treatment center in Lima, Peru
por: Castillo, N, et al.
Publicado: (2010)

Effective HAART reduces the incidence of high grade cervical neoplasia in HIV positive women
por: Morris-Harris, Deborah, et al.
Publicado: (2012)

P20-01. HIV-1 genetic diversity among HIV drug naive populations of Nairobi, Kenya
por: Nyamache, AK, et al.
Publicado: (2009)

Relationship between dynamics of Epstein-Barr virus and immune activation in HIV-1 infected subjects in the HAART era
por: Cattelan, AM, et al.
Publicado: (2010)

Smoking, female gender and PI use are associated with decreasing renal function in TDF-containing HAART
por: Uglietti, A, et al.
Publicado: (2010)

Prevalence and risk factors for chronic obstructive lung disease in HIV-infected patients in the HAART era
por: Madeddu, G, et al.
Publicado: (2010)

P16-49. Broad types of cytokines secreted by Gag-specific T cells from HIV infected patients on HAART
por: Montes, M, et al.
Publicado: (2009)

Hepatitis B and C Co-Infections in Some HIV-Positive Populations in Cameroon, West Central Africa: Analysis of Samples Collected Over More Than a Decade
por: Noubiap, Jean Jacques N., et al.
Publicado: (2015)

Efficacy and safety of therapy of chronic hepatitis B with telbivudine (LdT) in patients with HIV-infection without HAART
por: Tsarenko, SP, et al.
Publicado: (2010)

Interventions to promote adherence to Antiretroviral Therapy (HAART) among adult patients at an HIV/AIDS program in Uganda
por: Muhumuza, Simon, et al.
Publicado: (2010)

High levels of polymorphisms related to raltegravir resistance among raltegravir-naïve individuals in Brazil
por: Pena, N Mantovani, et al.
Publicado: (2010)

Effect of vasoactive drugs on the response of the baroreceptor and regulation of heart rate variability in patients with septic shock
por: Nogueira, AC, et al.
Publicado: (2013)

Efficacy and safety of TDF/FTC-containing, first-line HAART in clinical practice: 3-year data from the German outpatient cohort
por: van Lunzen, J, et al.
Publicado: (2010)

Impact of timing HAART initiation on immune status and clinical course in the cohort of the German competence network for HIV/AIDS
por: Plettenberg, A, et al.
Publicado: (2010)

Impact of short term HAART initiated during the acute or chronic stage on SIV infection of the male genital tract
por: Moreau, Marina, et al.
Publicado: (2010)

Home visiting to an HIV positive patient prior to initiation of HAART has Lasting impact on their adherence. TASO Experience
por: Odeke, Emmanuel, et al.
Publicado: (2010)

Lipid Peroxidation and Total Cholesterol in HAART-Naïve Patients Infected with Circulating Recombinant Forms of Human Immunodeficiency Virus Type-1 in Cameroon
por: Teto, Georges, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jl8pej1puf8imhc3efmsuv6tdq